Loading…
Reported covered position: Director, Business Outreach and Member Services, Republican Study Committee Legislative Clerk, House Energy and Commerce Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Mikaela Naylon Give Kids a Chance Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FIRST PRINCIPLES STRATEGIES LLC ON BEHALF OF IMMIX BIOPHARMA, INC via YC CONSULTING, LLC
2026 · third_quarter · Q3
Advancement of Congressional rare disease drug approval policies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
FIRST PRINCIPLES STRATEGIES LLC ON BEHALF OF IMMIX BIOPHARMA, INC via YC CONSULTING, LLC
2026 · third_quarter · RA
Source: Senate LDA
| AMERICAN OPTOMETRIC ASSOCIATION | 8 | 2025–2026 |
| CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. | 5 | 2025–2026 |
| CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS | 5 | 2025–2026 |
| GENENTECH INC | 5 | 2025–2026 |
| LOCKED BRANDS, LLC | 4 | 2025 |
| CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. | 3 | 2025–2026 |
| DOLLAR TREE MANAGEMENT, LLC | 3 | 2026 |
| EAGLE EYE X, INC. | 3 | 2023–2024 |
| FIRST PRINCIPLES STRATEGIES LLC ON BEHALF OF IMMIX BIOPHARMA, INC | 2 | 2026 |
| MAYFLOWER PARTNERS INTERNATIONAL LLC | 1 | 2023 |
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Combating Organized Retail Crime Act of 2025
Client: DOLLAR TREE MANAGEMENT, LLC · Firm: YC CONSULTING, LLC
H.R. 2853/S. 1404, Combating Organized Retail Crime Act of 2025
ETHIC Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
ETHIC Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
ETHIC Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Carla Walker Act
Client: CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. · Firm: YC CONSULTING, LLC
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence; H.R.3591 - Carla Walker Act, all provisions related to forensic evidence.
Joint Reserve Detachment (JRD) Formalization Act
Client: GENENTECH, INC. · Firm: YC CONSULTING, LLC
H.R. 3599, SECURE 340B Act, Issues related to drug pricing and patient access
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 4687, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 4687, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 4687, Partner with Korea Act
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Combating Organized Retail Crime Act
Client: DOLLAR TREE MANAGEMENT, LLC · Firm: YC CONSULTING, LLC
H.R. 2853/S. 1404, Combating Organized Retail Crime Act of 2025
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill Act - healthcare provisions Prescription Drug Pricing Policy
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill - healthcare provisions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill - healthcare provisions
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Mikaela Naylon Give Kids a Chance Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill - healthcare provisions
Mikaela Naylon Give Kids a Chance Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Mikaela Naylon Give Kids a Chance Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Mikaela Naylon Give Kids a Chance Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act Prescription Drug Pricing Policy
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill Act - healthcare provisions Prescription Drug Pricing Policy
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill - healthcare provisions
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
H.R. 1521, DOC Access Act of 2025
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R.2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Carla Walker Act
Client: CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. · Firm: YC CONSULTING, LLC
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence; H.R.3591 - Carla Walker Act, all provisions related to forensic evidence.
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 4687, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 4687, Partner with Korea Act
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill - healthcare provisions
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Vision Lab Choice Act of 2025
Client: AMERICAN OPTOMETRIC ASSOCIATION · Firm: YC CONSULTING, LLC
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Generating Retirement Ownership through Long-Term Holding
Client: CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS · Firm: YC CONSULTING, LLC
H.R.2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill - healthcare provisions
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R.2827/S.1301, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R.2827/S.1301, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R.2827/S.1301, Partner with Korea Act
Partner with Korea Act
Client: KOREA INTERNATIONAL TRADE ASSOCIATION · Firm: YC CONSULTING, LLC
H.R.2827/S.1301, Partner with Korea Act
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R.2880 - Protecting Patients Against PBM Abuses Act
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
Protecting Patients Against PBM Abuses Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY · Firm: YC CONSULTING, LLC
H.R. 4820/S. 2437, Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2024 Appropriations Bill
Protecting Health Care for All Patients Act of 2023
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Protecting Health Care for All Patients Act of 2023
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Protecting Health Care for All Patients Act of 2023
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Protecting Health Care for All Patients Act of 2023
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.830/S.1375, HELP Copays Act H.R.5378, Lowering Costs, More Transparency Act H.R.6427/S.3316, Immediate Access for the Terminally Ill Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act)
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R.2880 - Protecting Patients Against PBM Abuses Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.830/S.1375, HELP Copays Act H.R.5378, Lowering Costs, More Transparency Act H.R.6427/S.3316, Immediate Access for the Terminally Ill Act
Lower Costs, More Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Affordable Care and Comprehensive Economic Support through Savings Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Affordable Care and Comprehensive Economic Support through Savings Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Affordable Care and Comprehensive Economic Support through Savings Act
Client: PATIENTS RISING NOW · Firm: YC CONSULTING, LLC
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
DRUG Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
DRUG Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: YC CONSULTING, LLC
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R.2880 - Protecting Patients Against PBM Abuses Act
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Rare Disease therapeutic policies
DOLLAR TREE MANAGEMENT, LLC via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 2853/S. 1404, Combating Organized Retail Crime Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. via YC CONSULTING, LLC
2026 · third_quarter · Q3
Educating members of Congress on Aersale's AerAware technology and other aviation solutions.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 3599, SECURE 340B Act, Issues related to drug pricing and patient access
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2026 · third_quarter · Q3
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 4687, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2026 · third_quarter · Q3
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2027 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2026 · third_quarter · Q3
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Prescription Drug Pricing Policy
Filing targets: HOUSE OF REPRESENTATIVES
DOLLAR TREE MANAGEMENT, LLC via YC CONSULTING, LLC
2026 · second_quarter · Q2
Advocating on issues related to taxes and trade
Advocating on issues related to taxes and trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. via YC CONSULTING, LLC
2026 · second_quarter · Q2
Educating members of Congress on Aersale's AerAware technology and other aviation solutions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS via YC CONSULTING, LLC
2026 · second_quarter · Q2
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via YC CONSULTING, LLC
2026 · second_quarter · Q2
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Issues related to drug pricing and patient access
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2026 · second_quarter · Q2
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2026 · second_quarter · Q2
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2026 · second_quarter · Q2
H.R. 4687, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2026 · second_quarter · Q2
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2027 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2026 · second_quarter · Q2
Prescription Drug Pricing Policy
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Filing targets: HOUSE OF REPRESENTATIVES
DOLLAR TREE MANAGEMENT, LLC via YC CONSULTING, LLC
2026 · second_quarter · RR
Organized retail crime, tax and trade policy, and issues impacting retailers.
Organized retail crime, tax and trade policy, and issues impacting retailers.
CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. via YC CONSULTING, LLC
2026 · first_quarter · Q1
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence; H.R.3591 - Carla Walker Act, all provisions related to forensic evidence.
Director, Business Outreach and Member Services, Republican Study Committee Legislative Clerk, House Energy and Commerce Committee
Filing targets: HOUSE OF REPRESENTATIVES
PATIENTS RISING NOW via YC CONSULTING, LLC
2026 · first_quarter · Q1
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2026 · first_quarter · Q1
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2027 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2026 · first_quarter · Q1
H.R. 4687, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2026 · first_quarter · Q1
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2026 · first_quarter · Q1
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via YC CONSULTING, LLC
2026 · first_quarter · Q1
Issues related to drug pricing and patient access
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Filing targets: HOUSE OF REPRESENTATIVES
CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. via YC CONSULTING, LLC
2026 · first_quarter · Q1
Educating members of Congress on Aersale's AerAware technology and other aviation solutions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS via YC CONSULTING, LLC
2026 · first_quarter · Q1
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2026 · first_quarter · Q1
Prescription Drug Pricing Policy
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2025 · fourth_quarter · 4T
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act Prescription Drug Pricing Policy
Biopharmaceutical patent and intellectual property policy issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
H.R. 4687, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2026 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOCKED BRANDS, LLC via YC CONSULTING, LLC
2025 · fourth_quarter · 4T
Healthcare issues related to medication adherence
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing and patient access
Filing targets: HOUSE OF REPRESENTATIVES
CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
H.R. 2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
Educating members of Congress on Aersale's AerAware technology and other aviation solutions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · Q4
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence; H.R.3591 - Carla Walker Act, all provisions related to forensic evidence.
Director, Business Outreach and Member Services, Republican Study Committee Legislative Clerk, House Energy and Commerce Committee
Filing targets: HOUSE OF REPRESENTATIVES
CAPITOL VENTURE LLC ON BEHALF OF OTHRAM, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · RR
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence.
Educating members of the U.S. House and Senate on Othram's ability to apply the power of modern parallel sequencing to forensic evidence.
CAPITOL VENTURE LLC ON BEHALF OF AERSALE, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · RR
Educating members of Congress on AerSale's AerAware technology and other aviation solutions.
CAPITOL VENTURE LLC ON BEHALF OF MEEDER FUNDS via YC CONSULTING, LLC
2025 · fourth_quarter · RR
H.R.2089, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment, and S.1839, Generating Retirement Ownership through Long-Term Holding, all provisions relating to mutual funds tax treatment.
GENENTECH, INC. via YC CONSULTING, LLC
2025 · fourth_quarter · RR
Drug pricing and patient access issues
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2025 · third_quarter · Q3
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
LOCKED BRANDS, LLC via YC CONSULTING, LLC
2025 · third_quarter · Q3
Healthcare issues related to medication adherence
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2025 · third_quarter · Q3
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2025 · third_quarter · Q3
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2025 · third_quarter · Q3
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2026 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2025 · third_quarter · Q3
H.R. 4687, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2025 · third_quarter · Q3
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill Act - healthcare provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2025 · third_quarter · Q3
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill Act - healthcare provisions Prescription Drug Pricing Policy
Tariff policy issues
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB)
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2025 · second_quarter · Q2
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2026 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOCKED BRANDS, LLC via YC CONSULTING, LLC
2025 · second_quarter · Q2
Healthcare issues related to medication adherence
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2025 · second_quarter · Q2
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2025 · second_quarter · Q2
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2025 · second_quarter · Q2
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
PATIENTS RISING NOW via YC CONSULTING, LLC
2025 · second_quarter · Q2
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025 H.R. 1, One Big Beautiful Bill - healthcare provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2025 · second_quarter · Q2
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill - healthcare provisions
Filing targets: HOUSE OF REPRESENTATIVES
LOCKED BRANDS, LLC via YC CONSULTING, LLC
2025 · second_quarter · RR
Healthcare issues related to medication adherence
Healthcare issues related to medication adherence
PATIENTS RISING NOW via YC CONSULTING, LLC
2025 · first_quarter · Q1
H.R. 1262/S. 932, Give Kids A Chance Act of 2025 H.R. 955, HOPE Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2025 · first_quarter · Q1
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2025 · first_quarter · Q1
H.R. 1521, DOC Access Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2025 · first_quarter · Q1
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2025 · first_quarter · Q1
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2026 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2025 · first_quarter · Q1
H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN OPTOMETRIC ASSOCIATION via YC CONSULTING, LLC
2025 · first_quarter · RR
Legislation related to optometric care access
DISPOSE RX, INC. via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
H.R.2827/S.1301, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2025 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2024 · fourth_quarter · Q4
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DISPOSE RX, INC. via YC CONSULTING, LLC
2024 · fourth_quarter · RR
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
Issues related to eliminating and preventing the misuse of unused prescriptions through safe medication disposal solutions.
PATIENTS RISING NOW via YC CONSULTING, LLC
2024 · third_quarter · Q3
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2024 · third_quarter · Q3
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2024 · third_quarter · Q3
H.R.2827/S.1301, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2024 · third_quarter · Q3
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2025 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2024 · third_quarter · Q3
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R. 2880 - Protecting Patients Against PBM Abuses Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2024 · second_quarter · Q2
Issues related to designating collegiate athletes as employees.
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EAGLE EYE X, INC. via YC CONSULTING, LLC
2024 · second_quarter · Q2
Issues related to use of new technology solutions for environmental protection (generally, no specific legislation).
Filing targets: Export-Import Bank of the United States (EXIM Bank), HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2024 · second_quarter · Q2
H.R.2827/S.1301, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2024 · second_quarter · Q2
Issues related to the Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2025 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2024 · second_quarter · Q2
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2024 · second_quarter · Q2
Issues related to intellectual property and patents
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act) H.R.2880 - Protecting Patients Against PBM Abuses Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EAGLE EYE X, INC. via YC CONSULTING, LLC
2024 · first_quarter · Q1
Issues related to use of new technology solutions for environmental protection (generally, no specific legislation).
Filing targets: Export-Import Bank of the United States (EXIM Bank), HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2024 · first_quarter · Q1
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Issues related to designating collegiate athletes as employees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2024 · first_quarter · Q1
H.R.2827/S.1301, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2024 · first_quarter · Q1
H.R. 4820/S. 2437, Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2024 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2024 · first_quarter · Q1
H.R.485, Protecting Health Care for All Patients Act H.R.830/S.1375, HELP Copays Act H.R.5378, Lowering Costs, More Transparency Act H.R.6427/S.3316, Immediate Access for the Terminally Ill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2024 · first_quarter · Q1
H.R. 5378 - Lower Costs, More Transparency Act H.R. 6283/S. 1542 - Delinking Revenue from Unfair Gouging Act (DRUG Act)
Issues related to intellectual property and patents
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2023 · fourth_quarter · Q4
Issues related to designating collegiate athletes as employees.
Issues related to policies concerning athletes benefiting from their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via YC CONSULTING, LLC
2023 · fourth_quarter · Q4
S.1542/H.R.6283, DRUG Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KOREA INTERNATIONAL TRADE ASSOCIATION via YC CONSULTING, LLC
2023 · fourth_quarter · Q4
H.R.2827/S.1301, Partner with Korea Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAVANNAH-GEORGIA CONVENTION CENTER AUTHORITY via YC CONSULTING, LLC
2023 · fourth_quarter · Q4
H.R. 4820/S. 2437, Transportation, Housing and Urban Development, and Related Agencies Fiscal Year 2024 Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENTS RISING NOW via YC CONSULTING, LLC
2023 · fourth_quarter · Q4
H.R.485, Protecting Health Care for All Patients Act H.R.830/S.1375, HELP Copays Act H.R.5378, Lowering Costs, More Transparency Act H.R.6427/S.3316, Immediate Access for the Terminally Ill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIDAL BASIN ADVISORS ON BEHALF OF THE COLLECTIVE ASSOCIATION via YC CONSULTING, LLC
2023 · fourth_quarter · RA
Issues related to policies concerning athletes benefiting from their name, image, and likeness; Issues related to designating collegiate athletes as employees.
Issues related to policies concerning athletes benefiting from their name, image, and likeness; Issues related to designating collegiate athletes as employees.